A Phase 1 Study of Inotuzumab Ozogamicin (CMC-544) Administered in Combination With Rituximab in Subjects With B-Cell Non-Hodgkin's Lymphoma
Phase of Trial: Phase I
Latest Information Update: 05 Nov 2016
At a glance
- Drugs Inotuzumab ozogamicin; Rituximab
- Indications B cell lymphoma
- Focus Adverse reactions
- Sponsors Pfizer
- 05 Nov 2016 Last checked against ClinicalTrials.gov record.
- 20 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.